Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 69 shares at $430.93 ($30K) on 2024-05-15, disclosed to the SEC on 2024-05-17.
Scheduled sale ($30k) by EVP, COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |
| VRTX | SELL | 2023-12-15 | $3.4M | — | Filing → |